Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225238 · ClinicalTrials.gov registry record · Phase 4
The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep
A Phase 4 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
NCT00225238 is a Phase 4 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 500 participants.
The verdict
NCT00225238, a Phase 4 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to ascertain if the use of Nexium for 7 days prior to taking a colon prep for a colonoscopy will decrease the side effects that are associated with the colon preparation
Interventions
- DRUG esomeprazole (PPI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225238
The ClinicalTrials.gov registry entry for NCT00225238 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which esomeprazole (PPI) is the first listed.
NCT00225238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00225238 about?
NCT00225238 is a clinical study titled "The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep". The purpose of this study is to ascertain if the use of Nexium for 7 days prior to taking a colon prep for a colonoscopy will decrease the side effects that are associated with the colon preparation
What is the current status of trial NCT00225238?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2003-12. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00225238?
The interventions under investigation include: esomeprazole (PPI) (DRUG).
Who is sponsoring clinical trial NCT00225238?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.